Page last updated: 2024-10-29

iohexol and Heritable Pulmonary Arterial Hypertension

iohexol has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pienn, M1
Kovacs, G1
Tscherner, M1
Johnson, TR1
Kullnig, P1
Stollberger, R1
Olschewski, A1
Olschewski, H1
Bálint, Z1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography - Pilot Study[NCT01607489]25 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for iohexol and Heritable Pulmonary Arterial Hypertension

ArticleYear
Determination of cardiac output with dynamic contrast-enhanced computed tomography.
    The international journal of cardiovascular imaging, 2013, Volume: 29, Issue:8

    Topics: Adult; Aged; Aorta; Aortography; Cardiac Catheterization; Cardiac Output; Contrast Media; Familial P

2013